SkinVision, a clinically validated app with three million users globally, is spearheading the use of AI in frontline healthcare with a unique combination of AI and medical oversight that delivers 90 per cent-plus diagnostic accuracy via a smartphone programme that instantly analyses marks on the skin.
The growing use of AI in healthcare is proving a critical asset to clinicians as they deal with ever-increasing demands across resource-stressed healthcare systems.
“Our 2024 data from the UK shows that 5.7 per cent of people concerned about a specific skin issue require an in-person follow-up with a healthcare professional,” says Erik de Heus, CEO, SkinVision.
If we fail to embrace AI, patients will continue to suffer, clinicians will remain frustrated and healthcare systems, such as the NHS, will struggle to deliver the treatment patients need.
As this collaboration deepens, it will unlock new possibilities for early diagnosis, personalised care and streamlined healthcare delivery, ensuring that technology and human ingenuity work hand in hand to meet the growing demands of cutting-edge healthcare.
